Prevalence of hepatitis C virus infection in the general population and patients with liver disease in China

Hepatology Research

Volumn 14, Issue 2, 1999, Pages 135-143

  Xuezhong, Lei ^a   Naitoh, Shigeko ^b   Xuewen, Deng ^b   Song, Wang ^a   San, Qin ^a   Li, Liu ^a   Hong, Tang ^a   Liansan, Zhao ^a   Bingjun, Lei ^a   Akahane, Yoshihiro ^b  

^a WEST CHINA UNIVERSITY OF MEDICAL SCIENCES   (China)

^b UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Chronic liver disease; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Southwest China

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN;

ARTICLE; CHINA; CHRONIC LIVER DISEASE; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; LIVER CELL CARCINOMA; PREVALENCE; PRIORITY JOURNAL; SEROCONVERSION; TREATMENT PLANNING; VACCINATION; VIRUS DETECTION; VIRUS PATHOGENESIS; VIRUS VIRULENCE;

EID: 0032906240     PISSN: 09284346     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1386-6346(98)00119-3     Document Type: Article

References (33)

1. Li Y. An epidemiological study on viral hepatitis. Chin J Microbiol Immunol. 1:1986;S1-15.
2. Qu Z.Y. An epidemiological study on the distribution of HBsAg and anti-HBs in China. Chin J Microbiol Immunol. 1:1986;S0-39.
3. Tao Q.M., Wang Y., Du S.C., Guo J.P. Epidemiology of hepatitis B and C in China. Nishioka K., Suzuki H., Mishiro S., Oda T. Viral Hepatitis and Liver Disease. 1994;412-415 Springer, Tokyo.
4. Xia G.L., Liu C.B., Cao H.L. et al. Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992. Int Hepatol Commun. 5:1996;62-73.
5. Yano M., Yatsuhashi H., Inoue O., Inokuchi K., Koga M. Epidemiology and long term prognosis of hepatitis C virus infection in Japan. Gut. 34:1993;S13-16.
6. Tsai J.F., Jeng J.E., Chang W.Y., Lin Z.Y., Tsai J.H. Hepatitis C virus infection among patients with chronic liver disease in an area hyperendemic for hepatitis B. Scand J Gastroenterol. 29:1994;550-552.
7. Bruix J., Barrera J.M., Calvet X. et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet. 2:1989;1004-1006.
8. Plagemann P.G.W. Hepatitis C virus (review). Arch Virol. 120:1991;165-180.
9. Rassam S.W., Dusheiko G.M. Epidemiology and transmission of hepatitis C infection (editorial). J Gastroenterol Hepatol. 3:1991;585-591.
10. van der Poel C.L., Reesink H.W., Lelie P.N. et al. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands. Lancet. 2:1989;297-298.
11. Esteban J.I., Gonzalez A., Hernandez J.M. et al. Evaluation of antibodies to hepatitis C virus in a study of transfusion- associated hepatitis. New Engl J Med. 323:1990;1107-1112.
12. Chiaramonte M., Stroffolini T., Caporaso N. et al. Hepatitis-C virus infection in Italy: a multicentric sero-epidemiological study. Ital J Gastroenterol. 23:1991;555-558.
13. Kwok S., Higuchi R. Avoiding false positives with PCR. Nature. 339:1989;237-238.
14. Lee H.S., Kim C.Y. Seroepidemiology of HBV and HCV in Korea: the decreasing prevalence rate of HBV infection after launching HB vaccination program. Int Hepatol Commun. 5:1996;53-61.
15. Tong M.J., el-Farra N.S., Reikes A.R., Co R.L. Clinical outcomes after transfusion-associated hepatitis C. New Engl J Med. 332:1995;1463-1466.
16. De Bac C., Stroffolini T., Gaeta G.B., Taliani G., Giusti G. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter Italian study. Hepatology. 20:1994;1225-1230.
17. Lee H.S., Han C.J., Kim C.Y. Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B-endemic area. Cancer. 72:1993;2564-2567.
18. Saito I., Miyamura T., Ohbayashi A. et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA. 87:1990;6547-6549.
19. Alter M.J, Mast E.E. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am. 23:1994;437-455.
20. Alter M.J. Epidemiology of hepatitis C in the West. Semin Liver Dis. 15:1995;5-14.
21. Tandon B.N., Acharya S.K., Tandon A. Seroepidemiology of HBV and HCV in India. Strategy for control of maternal transmission of HBV and its effect. Screening methods of blood donors for control of post-transfusion hepatitis and their effects. Int Hepatol Commun. 5:1996;14-18.
22. Suwignyo S. Seroepidemiology of hepatitis B and C in Indonesia. Int Hepatol Commun. 5:1996;30-37.
23. Leung N.W., Tam J.S., Lai J.Y. et al. Does hepatitis C virus infection contribute to hepatocellular carcinoma in Hong Kong? Cancer. 70:1992;40-44.
24. Wang JT, Wang TH, Lin JT, Sheu JC, Sung JL, Chen DS. Hepatitis C virus in a prospective study of post-transfusion non-A, non-B hepatitis in Taiwan. J Med Virol 1990;32:83-86.
25. Aach R.D., Stevens C.E., Hollinger F.B. et al. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. New Engl J Med. 325:1991;1325-1329.
26. Peters T., Schlayer H.J., Preisler S. et al. Frequency of hepatitis C in acute post-transfusion hepatitis after open- heart surgery: a prospective study in 1476 patients. J Med Virol. 39:1993;139-145.
27. Yoshizawa H., Watanabe J. Impacts of blood screening on the incidence of post-transfusion hepatitis C in Japan. Curr Stud Hematol Blood Transf. 61:1994;182-194.
28. Nelson K., Ahmed F., Ness P.M. et al. Efficacy of donor screening methods on reducing the risk of transfusion transmission of hepatitis C virus (HCV). 1993;40 Fourth International Symposium on HCV, May 7-9, Tokyo, Japan.
29. Sung J.L. National strategies for viral hepatitis B, C and hepatocellular carcinoma in Taiwan. Int Hepatol Commun. 5:1996;43-52.
30. Yoshizawa H. Blood screening to prevent post-transfusion hepatitis in Japan: effective for prevention as well as revealing for epidemiology of HBV and HCV infection in healthy subjects. Int Hepatol Commun. 5:1996;79-87.
31. Donahue J.G., Munoz A., Ness P.M. et al. The declining risk of post-transfusion hepatitis C virus infection. New Engl J Med. 327:1992;369-373.
32. Kleinman S., Busch M., Holland P. Post-transfusion hepatitis C virus infection (letter). New Engl J Med. 327:1992;1601-1602.
33. Holland P.V. Viral infections and the blood supply (editorial). New Engl J Med. 334:1996;1734-1735.